ALIMERA SCIENCES, INC. Accounts Receivable
ALIMERA SCIENCES, INC. had Accounts Receivable of $37.08 million as of 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2024-08-07
- 2024-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $37.08M.
- 2024-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $34.22M.
- 2023-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $34.55M.
- 2023-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $33.94M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2024-06-30 | $37.08M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $34.22M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $34.55M 10-Q · filed 2024-08-07 |
| 2023-09-30 | $33.94M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $22.59M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $18.43M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $19.61M 10-K · filed 2024-03-08 |
| 2022-09-30 | $19.14M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $20.32M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $18.78M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $19.13M 10-K · filed 2023-03-31 |
| 2021-09-30 | $16.21M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $15.09M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $15.70M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $17.20M 10-K · filed 2022-03-23 |
| 2020-09-30 | $15.63M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $14.03M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $16.18M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $19.33M 10-K · filed 2021-03-05 |
| 2019-09-30 | $16.38M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $13.89M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $15.42M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $17.26M 10-K · filed 2020-03-02 |
| 2018-09-30 | $14.28M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $13.42M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $12.35M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $11.44M 10-K · filed 2019-02-25 |
| 2017-09-30 | $13.45M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $13.65M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $10.77M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $13.84M 10-K · filed 2018-03-02 |
| 2016-09-30 | $13.40M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $13.26M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $9.08M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $9.80M 10-K · filed 2017-03-03 |
| 2015-09-30 | $9.38M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $7.73M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $3.42M 8-K · filed 2015-09-18 |
| 2014-12-31 | $850.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $1.10M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $1.02M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $1.28M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $500.00K 8-K · filed 2015-09-18 |
| 2013-09-30 | $464.00K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $129.00K 10-Q · filed 2013-08-14 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-07 |